Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Access Pharmaceuticals, Inc.
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
September 19th, 2008
ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced that it had retained Piper Jaffray to augment ongoing business development efforts with the goal of establishing additional strategic development and commercialization partnerships for Access' extensive product pipeline and multiple technology platforms. The Piper Jaffray healthcare investment banking team will focus on partnering opportunities for ProLindac, Angiolix and the Cobalamin programs. "Access has a very deep pipeline of products and technologies, and working with the experienced Piper Jaffray team will augment our ongoing activities and accelerate our efforts on a global basis," stated Jeffrey B....
Source: Health Business Week (2008-09-19)
|
